Alopecia

Posts

CTP-543 THRIVE Clinical Program

CTP-543 THRIVE Clinical Program

/in /by

The Patient Recruiting Agency, LLC Announces Enrollment Launched for the CTP-543 THRIVE Clinical Program Investigating Oral Treatment for Moderate to Severe Alopecia Areata

The Patient Recruiting Agency™ announces open enrollment for the THRIVE Clinical Program, a series of clinical trials exploring the investigational product CTP-543 for the potential oral treatment of moderate to severe alopecia areata. CTP-543 is being developed by Concert Pharmaceuticals, Inc.

The purpose of the ongoing THRIVE Clinical Program is to measure the effect of CTP-543 on hair regrowth and to evaluate safety in people with alopecia areata.

The THRIVE Clinical Program is now enrolling adults 18 to 65 years old with at least 50% scalp hair loss due to alopecia areata. The current episode of hair loss must have lasted at least 6 months and no longer than 10 years. The total time a person has had alopecia areata may exceed 10 years.

Following a 24-week treatment period, participants will have the opportunity to enrol into an open-label extension study in which all participants will receive an active dose of CTP-543.

The THRIVE Clinical Program is being conducted at multiple research study centres throughout the United States and Canada. For more information about this important clinical research study, please visit our study website.

CTP-543 is a selective Janus kinase (JAK) inhibitor intended to disrupt the process that causes hair follicles to be incorrectly targeted by the body’s immune system. There are currently no FDA-approved treatments for alopecia areata.

US Thrive Clinical Program Website: https://www.mythrivestudy.com

Canadian Thrive Clinical Program Website: https://www.mythrivestudy.ca

About The Patient Recruiting Agency™

Located in Austin, Texas, The Patient Recruiting Agency™ (TPRA) supports Sponsors, CROs, SMOs, and Investigators with patient recruitment services.

The Patient Recruiting Agency, LLC Announces Enrollment Launched for the CTP-543 THRIVE Clinical Program Investigating Oral Treatment for Moderate to Severe Alopecia Areata

Source

Recent Posts

CTP-543 THRIVE Clinical Program

CTP-543 THRIVE Clinical Program

/in /by

The Patient Recruiting Agency, LLC Announces Enrollment Launched for the CTP-543 THRIVE Clinical Program Investigating Oral Treatment for Moderate to Severe Alopecia Areata

The Patient Recruiting Agency™ announces open enrollment for the THRIVE Clinical Program, a series of clinical trials exploring the investigational product CTP-543 for the potential oral treatment of moderate to severe alopecia areata. CTP-543 is being developed by Concert Pharmaceuticals, Inc.

The purpose of the ongoing THRIVE Clinical Program is to measure the effect of CTP-543 on hair regrowth and to evaluate safety in people with alopecia areata.

The THRIVE Clinical Program is now enrolling adults 18 to 65 years old with at least 50% scalp hair loss due to alopecia areata. The current episode of hair loss must have lasted at least 6 months and no longer than 10 years. The total time a person has had alopecia areata may exceed 10 years.

Following a 24-week treatment period, participants will have the opportunity to enrol into an open-label extension study in which all participants will receive an active dose of CTP-543.

The THRIVE Clinical Program is being conducted at multiple research study centres throughout the United States and Canada. For more information about this important clinical research study, please visit our study website.

CTP-543 is a selective Janus kinase (JAK) inhibitor intended to disrupt the process that causes hair follicles to be incorrectly targeted by the body’s immune system. There are currently no FDA-approved treatments for alopecia areata.

US Thrive Clinical Program Website: https://www.mythrivestudy.com

Canadian Thrive Clinical Program Website: https://www.mythrivestudy.ca

About The Patient Recruiting Agency™

Located in Austin, Texas, The Patient Recruiting Agency™ (TPRA) supports Sponsors, CROs, SMOs, and Investigators with patient recruitment services.

The Patient Recruiting Agency, LLC Announces Enrollment Launched for the CTP-543 THRIVE Clinical Program Investigating Oral Treatment for Moderate to Severe Alopecia Areata

Source

Recent Posts

Alopecia Treatment

Alopecia Treatment

/in /by

Global Alopecia Treatment (Hair Loss) Market – Industry Trends and Forecast to 2028

Alopecia treatment (hair loss) market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the alopecia treatment (hair loss) market to account to USD 5,461.35 million by 2028 growing at a CAGR of 6.0% in the above-mentioned forecast period. Rising prevalence of alopecia (hair loss) globally and extensive research & development activity in alopecia treatment (hair loss) has been directly impacting the growth of alopecia treatment (hair loss) market.

Alopecia is a condition that causes hair to fall out in small patches, which can be unnoticeable. These patches may connect, however, and then become noticeable. The condition develops when the immune system attacks the hair follicles, resulting in hair loss.

Increasing need for effective treatment for alopecia (hair loss) is the main driving factor for the alopecia treatment (hair loss) market. Rising pharmaceutical industries and various research & clinical studies is driving the alopecia treatment (hair loss) market. Various innovative clinical programmes is an opportunity for the alopecia treatment (hair loss) market.

Lack of awareness in rural countries is a big challenge for the alopecia treatment (hair loss) market. However, high cost of treatment is the main restraint in the growth of alopecia treatment (hair loss) market during the forecast period of 2021-2028.

This alopecia treatment (hair loss) market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market.

In March 2018, Johnson & Johnson Services, Inc. teamed up with JW Pharmaceutical to improve the sales of its product which is Rogaine, a hair loss treatment including minoxidil. JW Pharmaceutical has signed a distributorship agreement with J&J in November 2017. Rogaine is FDA approved hair loss treatment and is considered a top-selling hair loss treatment. This lead enabled the company to gain more product sales which have increased the company’s overall revenue.

Alopecia Treatment (Hair Loss) Market Scope and Market Size

Alopecia treatment (hair loss) market is segmented on the basis of disease type, treatment, gender, form, end user and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • Based on disease type, the alopecia treatment (hair loss) market is segmented into non‒cicatricial alopecia, cicatricial alopecia, traction alopecia and others.
  • Based on treatment, the alopecia treatment (hair loss) market is segmented into localized therapies, systemic therapies, medical devices and herbal treatment.
  • Based on gender, the alopecia treatment (hair loss) market is segmented into male and female.
  • Based on form, the alopecia treatment (hair loss) market is segmented into oral, topical and parenteral.
  • Based on end user, the alopecia treatment (hair loss) market is segmented into hospitals, home healthcare and dermatology centers.
  • Based distribution channel, the alopecia treatment (hair loss) market is segmented into direct tender, retail sales and pharmacies.

Alopecia Treatment (Hair Loss) Market Country Level Analysis

Alopecia treatment (hair loss) market is segmented into is analysed and market size insights and trends are provided by country, disease type, treatment, gender, form, end user and distribution channel as referenced above.

The countries covered in the alopecia treatment (hair loss) market is segmented into report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is likely to lead the alopecia treatment (hair loss) market. The regional market has been driven by common form of alopecia and people with alopecia aerate affects. However, growing market with new players is the main factor propelling the growth of the regional market. The market in Asia-Pacific is expected to exhibit a substantial growth rate during the forecast period 2021-2028 due to rise in prevalence of alopecia and rising usage of hair care therapies for the treatment.

The country section of the alopecia treatment (hair loss) market is segmented into report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

Alopecia treatment (hair loss) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for alopecia treatment (hair loss) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the alopecia treatment (hair loss) market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Alopecia Treatment (Hair Loss) Market Share Analysis

Alopecia treatment (hair loss) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to alopecia treatment (hair loss) market.

The major players covered in the alopecia treatment (hair loss) market report are Alès Groupe, Gerolymatos International SA, iGrow Laser, Lexington Intl., LLC., Curallux, LLC., Follicum AB, HCell Inc., Freedom Laser Therapy, Inc., Taisho Pharmaceutical Holdings Co., Ltd., Vita-Cos-Med Klett-Loch GmbH, Vitabiotics Ltd., WOCKHARDT, Teva Pharmaceuticals USA, Inc., Pfizer Inc., Par Pharmaceutical, GlaxoSmithKline plc, Dr. Reddy’s Laboratories Ltd., Abbott, Zydus Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., Cipla Inc., Sun Pharmaceutical Industries Ltd., Merck Sharp & Dohme Corp., Aurobindo Pharma, Perrigo Company plc, Viviscal Limited, Dr. Kurt Wolff GmbH & Co. KG, Nanogen, Labo International S.r.l., Watermans, WON TECH Co., Ltd., PureTech are among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Global Alopecia Treatment (Hair Loss) Market – Industry Trends and Forecast to 2028

Source

Recent Posts

Study in Alopecia Areata

Study in Alopecia Areata

/in /by

Concert Pharmaceuticals Presents Update on CTP-543 Long-Term Extension Study in Alopecia Areata During 2nd JAK Inhibitors Drug Development Summit

Concert Pharmaceuticals, Inc today will present an update from its ongoing open label, long-term extension study of the investigational medicine CTP-543 in patients with moderate to severe alopecia areata, an autoimmune disorder that results in patchy or complete hair loss.

The data show that relative to the previous Phase 2 study results of CTP-543, hair regrowth assessed by the Severity of Alopecia Tool (SALT) was maintained or improved in the great majority of patients through one year of continuous dosing with 12 mg twice-daily of CTP-543. Approximately 57% of participants receiving 12 mg of CTP-543 twice-daily following 52 weeks of dosing achieved a clinically meaningful SALT score of 20 or less. Dosing in the long-term extension study is ongoing, and patients completing the ongoing Phase 3 THRIVE-AA trials are eligible to enrol in the study. These data will

“With its Breakthrough Therapy designation, we are excited about the prospect of CTP-543 for the treatment of alopecia areata as we advance it through its Phase 3 clinical program.

Through the Phase 3 program and long-term extension study we are building a robust body of data to support our New Drug Application with the FDA, which we plan to file in early 2023,” said James V. Cassella, PhD, Concert’s Chief Development Officer, who made the oral presentation at the Summit. “We are committed to understanding how alopecia areata affects the whole person and are working diligently to advance CTP-543 as one of the first FDA-approved therapies for this serious autoimmune condition.”

“We believe Janus kinase inhibitors, or JAKs, are an important mechanism in the treatment of autoimmune disorders, including alopecia areata,” said Maryanne Senna, MD, principal investigator of the Hair Academic Innovative Research Unit at Massachusetts General Hospital. “Through clinical research, we are at a point where we better understand the utility of this class of medicines and believe for the first time that new treatments could be on the horizon.”

CTP-543 has been generally well-tolerated in the long-term extension study with only 4 of the 158 subjects entering the study discontinuing due to adverse events to date. Adverse events are consistent with those previously reported in the Phase 2 trials. Clinical labs for key haematology parameters appear stable across the long-term extension study relative to the end of treatment in the Phase 2 trials.

Details from the oral presentation, entitled “Update on Long-Term Safety & Efficacy of CTP-543, an Oral JAK Inhibitor, for the Potential Treatment of Alopecia Areata” will be available at 11:55 a.m. ET in the Scientific Presentations section of Concert’s website in connection with the meeting presentation.

About CTP-543 and Alopecia Areata

CTP-543 is an oral selective inhibitor of Janus kinases JAK1 and JAK2. The U.S. Food and Drug Administration (FDA) has granted CTP-543 Breakthrough Therapy designation for the treatment of adult patients with moderate to severe alopecia areata and Fast Track designation for the treatment of alopecia areata.

Alopecia areata is an autoimmune disease in which the immune system attacks hair follicles, resulting in partial or complete loss of hair on the scalp and body. Alopecia areata may affect approximately 1 million Americans at any given time1. The scalp is the most commonly affected area, but any hair-bearing site can be affected alone or together with the scalp. The onset of the disease can occur throughout life and affects both women and men. Alopecia areata can be associated with serious psychological consequences, including anxiety and depression. There are currently no drugs approved by the FDA for the treatment of alopecia areata.

The FDA selected alopecia areata as one of eight new disease areas that it focused on under its Patient-Focused Drug Development Initiative (PFDDI) in 2016-2017. The goal of the PFDDI is to bring patient perspectives into an earlier stage of product development. Following the FDA’s Patient-Focused Drug Development meeting held in September 2017 on alopecia areata, the FDA summarized the input shared by patients and patient representatives in a Voice of the Patient report.

About Concert

Concert Pharmaceuticals is a clinical-stage biopharmaceutical company that is developing small molecule drugs that it discovered through the application of its DCE Platform® (deuterated chemical entity platform). Selective incorporation of deuterium into known molecules has the potential, on a case-by-case basis, to provide better pharmacokinetic or metabolic properties, thereby enhancing their clinical safety, tolerability or efficacy. Concert’s lead product candidate is in late-stage development for the treatment of alopecia areata, a serious autoimmune dermatological condition. Concert is also assessing a number of earlier-stage pipeline candidates.

Concert Pharmaceuticals Presents Update on CTP-543 Long-Term Extension Study in Alopecia Areata During 2nd JAK Inhibitors Drug Development Summit

Source

Recent Posts

Alopecia Market Report

Alopecia Market Report

/in /by

2021-2027 Global Alopecia Market Report – Production and Consumption Professional Analysis (Impact of COVID-19)

This report elaborates the market size, market characteristics, and market growth of the Alopecia industry, and breaks down according to the type, application, and consumption area of Alopecia. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry._

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Alopecia in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19._x000D_

In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Alopecia market covered in Chapter 13:

Sun Pharmaceutical Industries Ltd
Follica, Inc.
Vita-Cos-Med Klett-Loch GmbH
Merck & Co., Inc.
Capillus
Cipla Inc.
Transitions Hair Pty Ltd
Lexington International LLC
Cirrus Hair Centers
Johnson and Johnson AG

In Chapter 6, on the basis of types, the Alopecia market from 2015 to 2025 is primarily split into:_x000D_

Alopecia Areata
Cicatricial Alopecia
Traction Alopecia
Alopecia Totalis
Alopecia Universalis
Androgenetic Alopecia
Others

In Chapter 7, on the basis of applications, the Alopecia market from 2015 to 2025 covers:_x000D_

Male
Female

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:_x000D_

United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:

North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others_x000D_
South America (Covered in Chapter 12)
Brazil
Others

Years considered for this report:

Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025

2021-2027 Global Alopecia Market Report – Production and Consumption Professional Analysis (Impact of COVID-19)

Source

Recent Posts

Alopecia Treatment Market Size

Alopecia Treatment Market Size

/in /by

Alopecia Treatment Market Size

Detailed study and analysis of the Global Alopecia Treatment Market highlights new trends in the Alopecia Treatment industry and provides companies with trading insights.

This study helps manufacturers, suppliers and investors, CEOs to identify opportunities and business optimization strategies to improve their value in the global Alopecia Treatment market. Provides important information for well-known companies that are one of the top-performing companies. The report provides comprehensive coverage of existing and potential markets as well as an assessment of competitiveness in changing market scenarios.

The latest Alopecia Treatment market research report entails a detailed examination of important aspects such as the scope, global demand, attractiveness, profitability, and potential of this vertical over 2020-2026. Moreover, it lays strong emphasis on the various sub-markets and uncovers the major growth avenues, followed by an in-depth examination of the competitive landscape.

As stated by the experts, the industry is anticipated to amass notable returns throughout the forecast period, registering XX% CAGR throughout.

The research literature also highlights the impact of Covid-19 and recommends multiple solutions for effectively handling the market turbulence. Apart from this, it also covers the recent acquisitions, partnerships, mergers, and other growth strategies of the leading players to help stakeholders in effortless decision-making.

Key features of the Alopecia Treatment market report:

  • Impact of the Covid-19 pandemic on the industry progression
  • Records of the total sales, total returns, and market shares
  • Key industry trends
  • Rewarding prospects
  • Growth rate approximations for the market
  • Advantages and disadvantages of using direct and indirect sales channels
  • Prominent distributors, dealers, and traders

Alopecia Treatment market segments covered in the report:

Geographical fragmentation: North America, Europe, Asia-Pacific, South America, Middle East & Africa

  • Market examination at country and regional level
  • Sales amassed, returns gathered, and industry shares acquired by each regional contributor
  • Estimations for the revenue and growth rate of each regional market over the forecast duration

Product types:

  • Topical Drugs
  • Oral Drugs
  • Injectable
  • Hair Transplant Services and Other
  • Pricing patterns for each product type
  • Market share evaluation on the basis of sales and returns garnered by each product segment

Application spectrum:

  • Hospitals
  • Dermatology And Trichology Clinics
  • Home Care Settings and Other
  • Product pricing considering the application reach
  • Revenue and sales accrued by each application category over the analysis period

Competitive dashboard:

  • The major players covered in Alopecia Treatment are:
  • Teva Pharmaceutical Industries
  • Taisho Pharmaceutical Holdings
  • Reddy’s Laboratories
  • Merck
  • Himalaya Drug
  • Johnsoni 1/4 ?Johnson
  • Cellmid andCipla
  • Business synopsis of the listed companies
  • Product and service range of the leading players
  • Accounts of the sales, pricing models, revenue, gross margin, and market share of each company
  • SWOT studies of the major companies
  • Evaluation of the industry’s concentration ratio and rate of commercialization
  • Assessment of the business strategies implemented by the leading companies

The Study Objectives are:

  • To analyze and research the global Alopecia Treatment status and future forecast involving production, revenue, consumption, historical data and forecast.
  • To present the key Alopecia Treatment manufacturers, production, revenue, market share, and recent development.
  • To split the breakdown data by regions, type, manufacturers and applications.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends, drivers, influence factors in global and regions.
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy:

  • Understand the demand for Alopecia Treatment to determine the viability of the market.
  • Identify the developed and emerging markets where Alopecia Treatment are offered.
  • Identify the challenge areas and address them.
  • Develop strategies based on the drivers, trends and highlights for each of the segments.
  • Evaluate the value chain to determine the workflow and to get an idea of the current position where you are placed.
  • Recognize the key competitors of this market and respond accordingly.
  • Knowledge of the initiatives and growth strategies taken up by the major companies and decide on the direction for further growth.
  • Define the competitive positioning by comparing the products and services with the key players in the market.

Alopecia Treatment Market Size

Source

Recent Posts

State-of-the-Art Hair Restoration Therapy

/in /by

Technology Used in COVID Vaccine Can Also Help With Hair Loss

A key piece of technology used to create the Pfizer and Moderna COVID vaccines is also found in a hi-tech injection therapy to battle hair loss for men and women. World-renowned hair restoration surgeon, Dr. Sara Wasserbauer, has incorporated exosome hair loss therapy into her armamentarium of treatments for her patients.

Exosome injection therapy is a relatively non-invasive, in-office treatment that has shown early promise to slow down hair loss and, possibly even promote impressive new hair growth within just a few months.

“Exosome hair therapy is a promising new therapy option for many hair loss patients who have either tried about other every kind of treatment or who are looking for a non-pharmaceutical or non-surgical solution for their hair loss,” explains Dr. Wasserbauer, a Diplomate of the American Board of Hair Restoration Surgery and Fellow of the International Society of Hair Restoration Surgery. “This is a simple and safe injection therapy utilizing exosomes that carry the same messenger RNA used in the COVID vaccine with one major difference; instead of being used to fight a potentially deadly virus, the mRNA is used to stimulate new hair growth.”

WHAT ARE EXOSOMES?

  • Tiny nanoparticles discovered by scientists 35 five years ago
  • Do not contain DNA
  • Used for intercellular signaling
  • Contain messenger RNA (mRNA) and microRNA (miRNA) that execute cell-to-cell communication

Exosomes contain various growth factors. They are collected from stem cells in a process that is FDA registered and inspected. “It is important to note, exosome therapy is not stem cell therapy, and there is no approved ‘stem cell therapy’ for hair loss,” explains Dr. Wasserbauer. “Exosomes are extracellular vesicles, like tiny balloons, that are released from stem cells. The vesicles trigger signaling pathways for growth and healing, like for repairing a broken bone or promoting hair growth.”

State-of-the-Art Hair Restoration Therapy

A recent study by researchers at North Carolina State University supports how these kinds of messenger cells could trigger hair regeneration. The scientists found hair follicles do not disappear when someone starts balding. Instead, the follicles shrink or atrophy and become inactive. If the cells around the hair follicles could be replenished, those smaller follicles might recover and grow thicker hair shafts.

The exosome hair therapy process is so simple that Dr. Wasserbauer and her team can do the treatment in one of her exam rooms in her office. The doctor injects the exosomes into the fatty layer of the scalp that surrounds hair to stimulate the cells around hair follicles. “In some cases, we even add microdermabrasion to create small micro wounds to help stimulate the exosomes,” says Dr. Wasserbauer. “This treatment and other injection therapies utilizing PRP (Platelet Rich Plasma) have shown impressively quick hair growth in some cases (click for example), and in many other cases, the growth continues for up to a year or more.”

Dr. Wasserbauer consults patients at multiple locations in Northern California. In addition to exosome hair therapy, she conducts a variety of other hair restoration procedures, including follicular unit hair transplantation (FUT or FUE), eyebrow and eyelash hair transplantation, scalp micro-pigmentation and low level light therapy. She is available for phone and virtual interviews to discuss any or all treatments.

About Dr. Wasserbauer, M.D., A.B.H.R.S., F.I.S.H.R.S.

Dr. Sara Wasserbauer is one of our nation’s leading hair restoration experts. In addition to her practice at three San Francisco offices, she currently serves as immediate Past-President of the Board of Directors for the American Board of Hair Restoration Surgeons. She also writes a monthly feature article for the ISHRS Hair Transplant Forum International and is a frequent media source on hair loss and related treatments. For more information, visit http://www.californiahairsurgeon.com

Source

Technology Used in COVID Vaccine Can Also Help With Hair Loss

Stem Cell Alopecia Treatment

Stem Cell Alopecia Treatment

/in /by

Global Stem Cell Alopecia Treatment Market By Indication, By Geographic Scope And Forecast

According to Verified Market Research, The Global Stem Cell Alopecia Treatment Market is growing at a faster pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2019 to 2026.

The Global Stem Cell Alopecia Treatment Market report provides a holistic evaluation of the market for the forecast period (2017–2026). The report comprises of various segments as well an analysis of the trends and factors that are playing a substantial role in the market. These factors; the market dynamics, involves the drivers, restraints, opportunities, and challenges through which the impact of these factors in the market are outlined. The drivers and restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market. The Global Stem Cell Alopecia Treatment Market study provides an outlook on the development of the market in terms of revenue throughout the prognosis period.

Alopecia is an autoimmune skin disease that mainly affects the hair follicles, resulting in hair loss. There are three types of alopecia namely, alopecia areata, alopecia totalis, and alopecia Universalis. Both children and adults of all age groups are capable of acquiring such disease. The stem cell is used as therapy for regenerating hair growth. This approach is minimally invasive and therefore eliminates the need for undergoing surgery. Such treatment is available in hospitals, and dermatology clinics.

Global Stem Cell Alopecia Treatment Market Outlook

In the report, the market outlook section mainly encompasses the fundamental dynamics of the market which include drivers, restraints, opportunities, and challenges faced by the industry. Drivers and restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market.

The market is in demand as people are more concerned about facial appearance and therefore adopting such treatment. The use of such treatment options is utilized more in dermatology clinics than in hospitals. The number of clinics offering the stem-cell alopecia treatment is surging as patients are adopting the minimally invasive way for treatment. The hormonal and nutritional imbalance among adults is driving market growth. Drugs for treating alopecia is already available in the market, but it comes with adverse side effects. Therefore, the market for stem cell alopecia treatment has a future scope.

Verified Market Research narrows down the available data using primary sources to validate the data and use it in compiling a full-fledged market research study. The report contains a quantitative and qualitative estimation of market elements which interests the client. The “Global Stem Cell Alopecia Treatment Market” is mainly bifurcated into sub-segments which can provide classified data regarding the latest trends in the market.

Global Stem Cell Alopecia Treatment Market Competitive Landscape

The “Global Stem Cell Alopecia Treatment Market” study report will provide a valuable insight with an emphasis on global market including some of the major players such as APEX Biologix, Belgravia Center, RepliCel, Riken Research Institute, Kerastem, Sanford Burnham Prebys Medical Discovery Institute. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

Global Stem Cell Alopecia Treatment Market, By Indication

• Male Pattern Baldness
• Female Pattern Baldness
• Others

Global Stem Cell Alopecia Treatment Market Geographic Scope

• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Rest of Asia Pacific
• Rest of the World

Global Stem Cell Alopecia Treatment Market By Indication, By Geographic Scope And Forecast

Source

Recent Posts

US Hair Transplant Procedure

Hair Transplant Services

Hair Transplant Services

/in /by

Hair Transplant Services Market Share

The hair transplant services market report is segmented on the basis of treatment type, gender, end-user and region & country level. Based upon treatment type, the hair transplant services market is classified into laser therapy, stem cell therapy, follicular unit transplant, follicular unit extraction, and others. On the basis of gender, the market is classified into female and male. On the basis of end-user, the market is classified into hospitals, hair transplant clinics, outpatient centers, and others. The global hair transplant services market classified on the basis of end-users and procedures.

Hair Transplant Services Market is valued at USD 5,008.4 Million in 2018 and expected to reach USD 7,989.9 Million by 2025 with the CAGR of 6.9% over the forecast period.

Market Analysis of Hair Transplant Services-

The hair transplant services market is predicted to grow at a significant growth rate due to rising hair-related problems. It has been observed that there has not been any specific age for hair-related problems, as it can occur to any gender at any age.

This has created a huge market opportunity due to the large population pool having hair-related problems and created the high demand deriving the hair transplant services market. Rising consciousness among a large number of the population regarding physical appearance is the main factor to boost the hair transplant services market.

Moreover, rising disposable income may also responsible for the rise in demand and may benefit the market to gain sufficient growth in the forecast years. The demand for hair transplant has grown tremendously due to a large number of the population facing hair loss, or hair-related problems which have grown in the past few years, globally. It has been estimated that approx., 40-45% of women and 60-65% of men have hair-related problems mainly hair loss because of multiple reasons such as genetics, stress, aging, or illness.

Growing medical tourism for hair transplant services and treatment especially in some European counties like Turkey and India is one of the major key factors driving the growth of the hair transplant services market.

Turkey has more than 300 specialty clinics specialized in hair transplantation, growing the inbound population in Turkey and India from other European countries and regions increasing the revenue generation for the hair transplant services market. Progressive technology, skilled healthcare professionals specialized for hair transplant and relatively economic hair transplant treatment are the main deriving factors responsible for increasing hair transplant market growth.

However, some adverse side effects of drugs used in the hair transplant treatment may hinder the market growth and may restrict the market expansion. Some people who have undergone hair transplantation treatment have experienced itching and rashes after using drugs post-treatment. Sometimes the side effects can be worsening to loss of vision which is very rare. In the recent past year’s people with other side effects such as chest pain; swelling of lips, tongue, hand, and feet; weight gain, palpitation and loss of consciousness has been registered which is expected to hinder the demand for hair transplant treatment, hence, restricting the hair transplant services market.

The regions covered in this hair transplant services market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, the market of hair transplant services is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, Africa, etc.

Key Players –

The major players operating in the hair transplant market are Aderans Company Limited, Bernstein Medical, Medicamat, Limmer Hair Transplant Center, PhotoMedex, Inc., Bosley, Cole Instruments, Ethics instruments, Medicamat, Restoration Robotics and others.

Rising Influences of Film and Fashion Industry Coupled with Efforts from Manufacturer Boosting the Market Growth

Manufacturers are making efforts to hold its strong market position in the hair transplant services market. Major Key players are more focusing on the strategic approaches such as novel product launches, geographic expansion and of their capacity; collaboration and partnerships are expected to propel the market with high growth and demand. For example, HairMax Inc. laser device has received ANVISA approval, which has been very advantageous for the company’s growth and expansion of its product portfolio. Rising in the product approvals increases commercial availability and thus strengthen the market growth. Additionally, some of the other factors influencing and deriving the market growth are media influence, growth of film and fashion industry, peer pressure for beauty and appearance, etc. Some health factors also play an instrumental role in deriving market growth. These are accidents, genetic issues, diseases like cancer or chemotherapy which cause loss of hair coupled with the growing number of hair transplant clinics and services are propelling the market growth.

North America and Europe are expected to be the most Prominent Market for the Hair Transplant Services

Geographically, Hair transplant services Market report is segmented into North America, Europe, Asia-Pacific and Rest of the World. North America, followed by Europe market are expected to dominate the global hair transplant services market owing to technological advancement which delivers better hair transplant services are likely to grow hair transplant services market. Furthermore, the introduction of a surgical hair transplant system such as ARTAS based on robotic technology has vastly shaped this market. Also, rising fashion industry influences and advertisement has greatly benefited hair transplant services market growth. Additionally, rising usage of hair transplant systems such as neograft which is performed in both men and women with the help of follicular unit extraction method is likely to boost the market growth in the coming years.

Key Benefits for Market Report–

  • Global market report covers in depth historical and forecast analysis.
  • Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
  • Global market report helps to identify opportunities in market place.
  • Global market report covers extensive analysis of emerging trends and competitive landscape.
Market Segmentation:-

By Treatment Type:

  • Laser Therapy
  • Stem Cell Therapy
  • Follicular Unit Transplant
  • Follicular Unit Extraction
  • Others

By Gender:

  • Female
  • Male

By End-User:

  • Hospitals
  • Hair Transplant Clinics
  • Outpatient Centers
  • Others

By Regional & Country Level:

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • France
    • Germany
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Hair Transplant Services Market Share

Source

Recent Posts

US Hair Transplant Procedure

Alopecia Therapeutics Industry Analysis

Alopecia Therapeutics Industry Analysis

/in /by

Androgenic Alopecia Therapeutics Industry Analysis, Market Size, Share, Trends, Growth and Forecast 2021 – 2029

Key Companies

Johnson & Johnson Merck GlaxoSmithKline Astellas Pharma Cipla Almirall Sun Pharma Reddy’s Laboratories Concert Pharmaceuticals RiverTown Therapeutics Brickell Biotech BiologicsMD Aclaris

Therapeutics Segmentation Covered By Type

Medicine Surgery By Application Hospital Clinic By Region :

Asia-Pacific: China, Southeast Asia, India, Japan, Korea, Oceania Europe : Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland North America : United States, Canada, Mexico Middle East & Africa : GCC, North Africa, South Africa South America : Brazil, Argentina, Columbia, Chile, Peru

Table of content

Chapter 1 Global Androgenic Alopecia Therapeutics Market Overview

1.1 Introduction
1.2 Taxonomy
1.2.1 By Product Type & End User
1.2.2 By Region
1.3 Drivers for Androgenic Alopecia Therapeutics Market
1.4 Restraints for Androgenic Alopecia Therapeutics Market
1.5 Opportunities for Androgenic Alopecia Therapeutics Market
1.6 Trends for Androgenic Alopecia Therapeutics Market
1.7 COVID-19 Impact Assessment on Androgenic Alopecia Therapeutics Industry
1.8 Macro-economic Factors
1.9 Regulatory Framework
1.10 Pricing Analysis by Region, 2020
1.11 Opportunity Map Analysis
1.12 Opportunity Orbits
1.13 Market Investment Feasibility Index
1.14 PEST Analysis
1.15 PORTERS Five Force Analysis
1.16 Go to Market Strategy
1.17 Value Chain Analysis
1.18 Cost Structure Analysis
1.19 Regional Market Share and BPS Analysis

Chapter 2

Table of content

Chapter 1 Global Androgenic Alopecia Therapeutics Market Overview
1.1 Introduction
1.2 Taxonomy
1.2.1 By Product Type & End User
1.2.2 By Region
1.3 Drivers for Androgenic Alopecia Therapeutics Market
1.4 Restraints for Androgenic Alopecia Therapeutics Market
1.5 Opportunities for Androgenic Alopecia Therapeutics Market
1.6 Trends for Androgenic Alopecia Therapeutics Market
1.7 COVID-19 Impact Assessment on Androgenic Alopecia Therapeutics Industry
1.8 Macro-economic Factors
1.9 Regulatory Framework
1.10 Pricing Analysis by Region, 2020
1.11 Opportunity Map Analysis
1.12 Opportunity Orbits
1.13 Market Investment Feasibility Index
1.14 PEST Analysis
1.15 PORTERS Five Force Analysis
1.16 Go to Market Strategy
1.17 Value Chain Analysis
1.18 Cost Structure Analysis
1.19 Regional Market Share and BPS Analysis

Chapter 2 Global Androgenic Alopecia Therapeutics Market Overview
2.1 Global Androgenic Alopecia Therapeutics Market by Product Type
2.1.1 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
2.1.2 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
2.1.3 Global Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Product Type, (2013-2020)
2.2 Global Androgenic Alopecia Therapeutics Market by End User
2.2.1 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
2.2.2 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
2.2.3 Global Androgenic Alopecia Therapeutics Market Attractiveness Analysis by End User, (2013-2020)
2.3 Global Androgenic Alopecia Therapeutics Market by Region
2.3.1 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
2.3.2 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
2.3.3 Global Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Region, (2013-2020)
2.4 Global Androgenic Alopecia Therapeutics Market Outlook (2013-2029)
2.4.1 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2013-2020)
2.4.2 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2021-2029)
2.5 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Regions
2.5.1 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
2.5.2 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
2.6 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Product Type
2.6.1 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
2.6.2 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
2.7 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by End User
2.7.1 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
2.7.2 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
2.8 Global Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate Comparison (2014-2029)
2.8.1 Global Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Region
2.8.2 Global Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Product Type
2.8.3 Global Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by End User
2.9 Global Androgenic Alopecia Therapeutics Market Share Comparison (2013-2029)
2.9.1 Global Androgenic Alopecia Therapeutics Market Share by Region
2.9.2 Global Androgenic Alopecia Therapeutics Market Share by Product Type
2.9.3 Global Androgenic Alopecia Therapeutics Market Share by End User

Chapter 3 North America Androgenic Alopecia Therapeutics Market Overview
3.1 North America Androgenic Alopecia Therapeutics Market by Product Type
3.1.1 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
3.1.2 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
3.1.3 North America Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Product Type, (2013-2020)
3.2 North America Androgenic Alopecia Therapeutics Market by End User
3.2.1 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
3.2.2 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
3.2.3 North America Androgenic Alopecia Therapeutics Market Attractiveness Analysis by End User, (2013-2020)
3.3 North America Androgenic Alopecia Therapeutics Market by Region
3.3.1 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
3.3.2 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
3.3.3 North America Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Region, (2013-2020)
3.4 North America Androgenic Alopecia Therapeutics Market Outlook (2013-2029)
3.4.1 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2013-2020)
3.4.2 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2021-2029)
3.5 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Regions
3.5.1 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
3.5.2 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
3.6 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Product Type
3.6.1 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
3.6.2 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
3.7 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by End User
3.7.1 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
3.7.2 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
3.8 North America Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate Comparison (2014-2029)
3.8.1 North America Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Region
3.8.2 North America Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Product Type
3.8.3 North America Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by End User
3.9 North America Androgenic Alopecia Therapeutics Market Share Comparison (2013-2029)
3.9.1 North America Androgenic Alopecia Therapeutics Market Share by Region
3.9.2 North America Androgenic Alopecia Therapeutics Market Share by Product Type
3.9.3 North America Androgenic Alopecia Therapeutics Market Share by End User

Chapter 4 Europe Androgenic Alopecia Therapeutics Market Overview
4.1 Europe Androgenic Alopecia Therapeutics Market by Product Type
4.1.1 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
4.1.2 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
4.1.3 Europe Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Product Type, (2013-2020)
4.2 Europe Androgenic Alopecia Therapeutics Market by End User
4.2.1 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
4.2.2 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
4.2.3 Europe Androgenic Alopecia Therapeutics Market Attractiveness Analysis by End User, (2013-2020)
4.3 Europe Androgenic Alopecia Therapeutics Market by Region
4.3.1 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
4.3.2 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
4.3.3 Europe Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Region, (2013-2020)
4.4 Europe Androgenic Alopecia Therapeutics Market Outlook (2013-2029)
4.4.1 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2013-2020)
4.4.2 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2021-2029)
4.5 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Regions
4.5.1 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
4.5.2 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
4.6 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Product Type
4.6.1 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
4.6.2 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
4.7 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by End User
4.7.1 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
4.7.2 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
4.8 Europe Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate Comparison (2014-2029)
4.8.1 Europe Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Region
4.8.2 Europe Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Product Type
4.8.3 Europe Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by End User
4.9 Europe Androgenic Alopecia Therapeutics Market Share Comparison (2013-2029)
4.9.1 Europe Androgenic Alopecia Therapeutics Market Share by Region
4.9.2 Europe Androgenic Alopecia Therapeutics Market Share by Product Type
4.9.3 Europe Androgenic Alopecia Therapeutics Market Share by End User

Chapter 5 Asia Pacific Androgenic Alopecia Therapeutics Market Overview
5.1 Asia Pacific Androgenic Alopecia Therapeutics Market by Product Type
5.1.1 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
5.1.2 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
5.1.3 Asia Pacific Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Product Type, (2013-2020)
5.2 Asia Pacific Androgenic Alopecia Therapeutics Market by End User
5.2.1 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
5.2.2 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
5.2.3 Asia Pacific Androgenic Alopecia Therapeutics Market Attractiveness Analysis by End User, (2013-2020)
5.3 Asia Pacific Androgenic Alopecia Therapeutics Market by Region
5.3.1 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
5.3.2 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
5.3.3 Asia Pacific Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Region, (2013-2020)
5.4 Asia Pacific Androgenic Alopecia Therapeutics Market Outlook (2013-2029)
5.4.1 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2013-2020)
5.4.2 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2021-2029)
5.5 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Regions
5.5.1 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
5.5.2 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
5.6 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Product Type
5.6.1 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
5.6.2 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
5.7 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by End User
5.7.1 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
5.7.2 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
5.8 Asia Pacific Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate Comparison (2014-2029)
5.8.1 Asia Pacific Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Region
5.8.2 Asia Pacific Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Product Type
5.8.3 Asia Pacific Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by End User
5.9 Asia Pacific Androgenic Alopecia Therapeutics Market Share Comparison (2013-2029)
5.9.1 Asia Pacific Androgenic Alopecia Therapeutics Market Share by Region
5.9.2 Asia Pacific Androgenic Alopecia Therapeutics Market Share by Product Type
5.9.3 Asia Pacific Androgenic Alopecia Therapeutics Market Share by End User

Chapter 6 South America Androgenic Alopecia Therapeutics Market Overview
6.1 South America Androgenic Alopecia Therapeutics Market by Product Type
6.1.1 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
6.1.2 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
6.1.3 South America Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Product Type, (2013-2020)
6.2 South America Androgenic Alopecia Therapeutics Market by End User
6.2.1 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
6.2.2 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
6.2.3 South America Androgenic Alopecia Therapeutics Market Attractiveness Analysis by End User, (2013-2020)
6.3 South America Androgenic Alopecia Therapeutics Market by Region
6.3.1 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
6.3.2 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
6.3.3 South America Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Region, (2013-2020)
6.4 South America Androgenic Alopecia Therapeutics Market Outlook (2013-2029)
6.4.1 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2013-2020)
6.4.2 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2021-2029)
6.5 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Regions
6.5.1 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
6.5.2 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
6.6 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Product Type
6.6.1 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
6.6.2 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
6.7 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by End User
6.7.1 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
6.7.2 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
6.8 South America Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate Comparison (2014-2029)
6.8.1 South America Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Region
6.8.2 South America Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Product Type
6.8.3 South America Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by End User
6.9 South America Androgenic Alopecia Therapeutics Market Share Comparison 2013-2029
6.9.1 South America Androgenic Alopecia Therapeutics Market Share by Region
6.9.2 South America Androgenic Alopecia Therapeutics Market Share by Product Type
6.9.3 South America Androgenic Alopecia Therapeutics Market Share by End User

Chapter 7 MEA Androgenic Alopecia Therapeutics Market Overview
7.1 MEA Androgenic Alopecia Therapeutics Market by Product Type
7.1.1 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
7.1.2 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
7.1.3 MEA Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Product Type, (2013-2020)
7.2 MEA Androgenic Alopecia Therapeutics Market by End User
7.2.1 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
7.2.2 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
7.2.3 MEA Androgenic Alopecia Therapeutics Market Attractiveness Analysis by End User, (2013-2020)
7.3 MEA Androgenic Alopecia Therapeutics Market by Region
7.3.1 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
7.3.2 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
7.3.3 MEA Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Region, (2013-2020)
7.4 MEA Androgenic Alopecia Therapeutics Market Outlook (2013-2029)
7.4.1 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2013-2020)
7.4.2 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2021-2029)
7.5 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Regions
7.5.1 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
7.5.2 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
7.6 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Product Type
7.6.1 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
7.6.2 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
7.7 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by End User
7.7.1 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
7.7.2 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
7.8 MEA Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate Comparison (2014-2029)
7.8.1 MEA Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Region
7.8.2 MEA Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Product Type
7.8.3 MEA Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by End User
7.9 MEA Androgenic Alopecia Therapeutics Market Share Comparison (2013-2029)
7.9.1 MEA Androgenic Alopecia Therapeutics Market Share by Region
7.9.2 MEA Androgenic Alopecia Therapeutics Market Share by Product Type
7.9.3 MEA Androgenic Alopecia Therapeutics Market Share by End User

Chapter 8 Global Androgenic Alopecia Therapeutics Market Company Profiles
8.1 Market Competition Scenario Analysis, By Company
8.2 Competitor Landscape
8.3 Company Share Analysis
8.4 Company Profiles
8.4.1 Company
8.4.1.1 Company Overview
8.4.1.2 Business Description
8.4.1.3 Product Portfolio
8.4.1.4 Key Financials
8.4.1.5 Key Developments
8.4.1.6 SWOT Analysis

Companies Included :
Johnson & Johnson
Merck
GlaxoSmithKline
Astellas Pharma
Cipla
Almirall
Sun Pharma
Reddy’s Laboratories
Concert Pharmaceuticals
RiverTown Therapeutics
Brickell Biotech
BiologicsMD
Aclaris Therapeutics

Chapter 9 Methodology and Data Source
9.1 Research Approach/ Methodology
9.2 Market Size Estimation
9.3 Market Breakdown and Data Triangulation
9.4 Data Source
9.4.1 Secondary Sources
9.4.2 Primary Sources

 

2.1 Global Androgenic Alopecia Therapeutics Market by Product Type
2.1.1 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
2.1.2 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
2.1.3 Global Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Product Type, (2013-2020)
2.2 Global Androgenic Alopecia Therapeutics Market by End User
2.2.1 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
2.2.2 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
2.2.3 Global Androgenic Alopecia Therapeutics Market Attractiveness Analysis by End User, (2013-2020)
2.3 Global Androgenic Alopecia Therapeutics Market by Region
2.3.1 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
2.3.2 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
2.3.3 Global Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Region, (2013-2020)
2.4 Global Androgenic Alopecia Therapeutics Market Outlook (2013-2029)
2.4.1 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2013-2020)
2.4.2 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2021-2029)
2.5 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Regions
2.5.1 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
2.5.2 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
2.6 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Product Type
2.6.1 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
2.6.2 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
2.7 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by End User
2.7.1 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
2.7.2 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
2.8 Global Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate Comparison (2014-2029)
2.8.1 Global Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Region
2.8.2 Global Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Product Type
2.8.3 Global Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by End User
2.9 Global Androgenic Alopecia Therapeutics Market Share Comparison (2013-2029)
2.9.1 Global Androgenic Alopecia Therapeutics Market Share by Region
2.9.2 Global Androgenic Alopecia Therapeutics Market Share by Product Type
2.9.3 Global Androgenic Alopecia Therapeutics Market Share by End User

Chapter 3 North America Androgenic Alopecia Therapeutics Market Overview

3.1 North America Androgenic Alopecia Therapeutics Market by Product Type
3.1.1 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
3.1.2 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
3.1.3 North America Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Product Type, (2013-2020)
3.2 North America Androgenic Alopecia Therapeutics Market by End User
3.2.1 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
3.2.2 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
3.2.3 North America Androgenic Alopecia Therapeutics Market Attractiveness Analysis by End User, (2013-2020)
3.3 North America Androgenic Alopecia Therapeutics Market by Region
3.3.1 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
3.3.2 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
3.3.3 North America Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Region, (2013-2020)
3.4 North America Androgenic Alopecia Therapeutics Market Outlook (2013-2029)
3.4.1 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2013-2020)
3.4.2 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2021-2029)
3.5 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Regions
3.5.1 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
3.5.2 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
3.6 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Product Type
3.6.1 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
3.6.2 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
3.7 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by End User
3.7.1 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
3.7.2 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
3.8 North America Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate Comparison (2014-2029)
3.8.1 North America Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Region
3.8.2 North America Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Product Type
3.8.3 North America Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by End User
3.9 North America Androgenic Alopecia Therapeutics Market Share Comparison (2013-2029)
3.9.1 North America Androgenic Alopecia Therapeutics Market Share by Region
3.9.2 North America Androgenic Alopecia Therapeutics Market Share by Product Type
3.9.3 North America Androgenic Alopecia Therapeutics Market Share by End User

Chapter 4 Europe Androgenic Alopecia Therapeutics Market Overview

4.1 Europe Androgenic Alopecia Therapeutics Market by Product Type
4.1.1 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
4.1.2 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
4.1.3 Europe Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Product Type, (2013-2020)
4.2 Europe Androgenic Alopecia Therapeutics Market by End User
4.2.1 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
4.2.2 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
4.2.3 Europe Androgenic Alopecia Therapeutics Market Attractiveness Analysis by End User, (2013-2020)
4.3 Europe Androgenic Alopecia Therapeutics Market by Region
4.3.1 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
4.3.2 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
4.3.3 Europe Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Region, (2013-2020)
4.4 Europe Androgenic Alopecia Therapeutics Market Outlook (2013-2029)
4.4.1 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2013-2020)
4.4.2 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2021-2029)
4.5 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Regions
4.5.1 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
4.5.2 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
4.6 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Product Type
4.6.1 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
4.6.2 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
4.7 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by End User
4.7.1 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
4.7.2 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
4.8 Europe Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate Comparison (2014-2029)
4.8.1 Europe Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Region
4.8.2 Europe Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Product Type
4.8.3 Europe Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by End User
4.9 Europe Androgenic Alopecia Therapeutics Market Share Comparison (2013-2029)
4.9.1 Europe Androgenic Alopecia Therapeutics Market Share by Region
4.9.2 Europe Androgenic Alopecia Therapeutics Market Share by Product Type
4.9.3 Europe Androgenic Alopecia Therapeutics Market Share by End User

Chapter 5 Asia Pacific Androgenic Alopecia Therapeutics Market Overview

5.1 Asia Pacific Androgenic Alopecia Therapeutics Market by Product Type
5.1.1 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
5.1.2 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
5.1.3 Asia Pacific Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Product Type, (2013-2020)
5.2 Asia Pacific Androgenic Alopecia Therapeutics Market by End User
5.2.1 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
5.2.2 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
5.2.3 Asia Pacific Androgenic Alopecia Therapeutics Market Attractiveness Analysis by End User, (2013-2020)
5.3 Asia Pacific Androgenic Alopecia Therapeutics Market by Region
5.3.1 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
5.3.2 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
5.3.3 Asia Pacific Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Region, (2013-2020)
5.4 Asia Pacific Androgenic Alopecia Therapeutics Market Outlook (2013-2029)
5.4.1 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2013-2020)
5.4.2 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2021-2029)
5.5 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Regions
5.5.1 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
5.5.2 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
5.6 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Product Type
5.6.1 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
5.6.2 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
5.7 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by End User
5.7.1 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
5.7.2 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
5.8 Asia Pacific Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate Comparison (2014-2029)
5.8.1 Asia Pacific Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Region
5.8.2 Asia Pacific Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Product Type
5.8.3 Asia Pacific Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by End User
5.9 Asia Pacific Androgenic Alopecia Therapeutics Market Share Comparison (2013-2029)
5.9.1 Asia Pacific Androgenic Alopecia Therapeutics Market Share by Region
5.9.2 Asia Pacific Androgenic Alopecia Therapeutics Market Share by Product Type
5.9.3 Asia Pacific Androgenic Alopecia Therapeutics Market Share by End User

Chapter 6 South America Androgenic Alopecia Therapeutics Market Overview

6.1 South America Androgenic Alopecia Therapeutics Market by Product Type
6.1.1 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
6.1.2 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
6.1.3 South America Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Product Type, (2013-2020)
6.2 South America Androgenic Alopecia Therapeutics Market by End User
6.2.1 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
6.2.2 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
6.2.3 South America Androgenic Alopecia Therapeutics Market Attractiveness Analysis by End User, (2013-2020)
6.3 South America Androgenic Alopecia Therapeutics Market by Region
6.3.1 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
6.3.2 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
6.3.3 South America Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Region, (2013-2020)
6.4 South America Androgenic Alopecia Therapeutics Market Outlook (2013-2029)
6.4.1 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2013-2020)
6.4.2 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2021-2029)
6.5 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Regions
6.5.1 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
6.5.2 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
6.6 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Product Type
6.6.1 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
6.6.2 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
6.7 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by End User
6.7.1 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
6.7.2 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
6.8 South America Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate Comparison (2014-2029)
6.8.1 South America Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Region
6.8.2 South America Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Product Type
6.8.3 South America Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by End User
6.9 South America Androgenic Alopecia Therapeutics Market Share Comparison 2013-2029
6.9.1 South America Androgenic Alopecia Therapeutics Market Share by Region
6.9.2 South America Androgenic Alopecia Therapeutics Market Share by Product Type
6.9.3 South America Androgenic Alopecia Therapeutics Market Share by End User

Chapter 7 MEA Androgenic Alopecia Therapeutics Market Overview

7.1 MEA Androgenic Alopecia Therapeutics Market by Product Type
7.1.1 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
7.1.2 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
7.1.3 MEA Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Product Type, (2013-2020)
7.2 MEA Androgenic Alopecia Therapeutics Market by End User
7.2.1 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
7.2.2 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
7.2.3 MEA Androgenic Alopecia Therapeutics Market Attractiveness Analysis by End User, (2013-2020)
7.3 MEA Androgenic Alopecia Therapeutics Market by Region
7.3.1 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
7.3.2 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
7.3.3 MEA Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Region, (2013-2020)
7.4 MEA Androgenic Alopecia Therapeutics Market Outlook (2013-2029)
7.4.1 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2013-2020)
7.4.2 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2021-2029)
7.5 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Regions
7.5.1 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
7.5.2 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
7.6 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Product Type
7.6.1 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
7.6.2 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
7.7 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by End User
7.7.1 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
7.7.2 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
7.8 MEA Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate Comparison (2014-2029)
7.8.1 MEA Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Region
7.8.2 MEA Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Product Type
7.8.3 MEA Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by End User
7.9 MEA Androgenic Alopecia Therapeutics Market Share Comparison (2013-2029)
7.9.1 MEA Androgenic Alopecia Therapeutics Market Share by Region
7.9.2 MEA Androgenic Alopecia Therapeutics Market Share by Product Type
7.9.3 MEA Androgenic Alopecia Therapeutics Market Share by End User

Chapter 8 Global Androgenic Alopecia Therapeutics Market Company Profiles

8.1 Market Competition Scenario Analysis, By Company
8.2 Competitor Landscape
8.3 Company Share Analysis
8.4 Company Profiles
8.4.1 Company
8.4.1.1 Company Overview
8.4.1.2 Business Description
8.4.1.3 Product Portfolio
8.4.1.4 Key Financials
8.4.1.5 Key Developments
8.4.1.6 SWOT Analysis

Companies Included :

Johnson & Johnson
Merck
GlaxoSmithKline
Astellas Pharma
Cipla
Almirall
Sun Pharma
Reddy’s Laboratories
Concert Pharmaceuticals
RiverTown Therapeutics
Brickell Biotech
BiologicsMD
Aclaris Therapeutics

Chapter 9 Methodology and Data Source

9.1 Research Approach/ Methodology
9.2 Market Size Estimation
9.3 Market Breakdown and Data Triangulation
9.4 Data Source
9.4.1 Secondary Sources
9.4.2 Primary Sources

Androgenic Alopecia Therapeutics Industry Analysis, Market Size, Share, Trends, Growth and Forecast 2021 – 2029

Source

Recent Posts

Stem Cell Alopecia Treatment Market

Stem Cell Alopecia Treatment

/in /by

U.S. PRP (Platelet Rich Plasma) and Stem Cell Alopecia Treatment Market

This insightful report has a lot to give on U.S. PRP (Platelet Rich Plasma) and Stem Cell Alopecia Treatment Market covering wide geographic scope around the world.

The U.S. PRP (Platelet Rich Plasma) and Stem Cell Alopecia Treatment Market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. The report is focused on gaining various market trends, dynamics, growth drivers, Strengths, weaknesses, opportunities, Threats restraining the market growth.

Further, the report offers detailed visions into various growth opportunities and challenges based on various types of products, applications, end-users and countries, among others.

The Key players operating in the U.S. PRP (Platelet Rich Plasma) and Stem Cell Alopecia Treatment Market are:

Orange County Hair Restoration Centre
Hair Sciences Centre of Colorado
Anderson Centre for Hair
Evolution Hair Loss Institute
Savola Aesthetic Dermatology Centre, PLC
NovaGenix
Virginia Surgical Centre
Hair Transplant Institute of Miami
Colorado Surgical Centre & Hair Institute
Tampa Bay Hair Restoration

Report Scope:

This report gives a complete view of the U.S. PRP (Platelet Rich Plasma) and Stem Cell Alopecia Treatment Market providing knowledgeable insights to the users. The report is verified and compiled by industry experts focusing on the key information that are required by the users or clients.

The Researchers have studied Marketing, government initiatives, political environment, and social scenarios that are likely to contribute to the growth of the regional markets. Analysis of various regional market trends, qualitative and quantitative data corresponding the market size for the years 2018 and 2019, estimates for 2020, and growth forecast for the period from 2021 to 2027.

Attractive investment propositions in the U.S. PRP (Platelet Rich Plasma) and Stem Cell Alopecia Treatment Market based on various segments such as product type, application, end-user etc. Key driving and success factors along with agony points in the form of growth drivers and restraints governing the market outlook along with future trend analysis.

Comprehensive company profiles giving visions into their supply chain analysis, Financial strategies, revenue information, product offerings, Market and Sales strategies and recent market activities.

Information on industry value chain analysis of the U.S. PRP (Platelet Rich Plasma) and Stem Cell Alopecia Treatment Market providing an investigative study of key stakeholders involved, which could expedite market participants in formulating appropriate strategies.

The competitive view of the xxx and market share analysis based on the company’s performance and customer reach. Insights on Competition, Customer and Market for making informed decisions.

Report Overview:

This project study is conducted with a global point of view in terms of the various segments in the U.S. PRP (Platelet Rich Plasma) and Stem Cell Alopecia Treatment Market. Market sizing and forecast have been conducted for 5 geographic regions viz. Europe, Middle East and Africa (MEA), North America, Latin America and Asia-Pacific along with the below-mentioned list of countries present in it. Market sizing data is covered in US$ with historic data for the years 2018 and 2019, 2020 as the base year along with estimations and forecast for the period from 2021 to 2028.

The ongoing COVID-19 pandemic has had a significant impact on overall international trade and businesses. This report provides the latest insights into the U.S. PRP (Platelet Rich Plasma) and Stem Cell Alopecia Treatment Market factoring in various effects of the industry disruptions and halts caused by COVID-19.

Market Segmentation:

U.S. PRP (Platelet Rich Plasma) and Stem Cell Alopecia Treatment Market, by Type:
Type 1
Type 2
Other Types

U.S. PRP (Platelet Rich Plasma) and Stem Cell Alopecia Treatment Market, by Application:

Application 1
Application 2
Other Applications

U.S. PRP (Platelet Rich Plasma) and Stem Cell Alopecia Treatment Market, by Geography:

North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Korea
SEA countries
Rest of Asia Pacific
Latin America
Brazil
Argentina
Peru
Rest of Latin America
Middle East and Africa (MEA)
GCC Countries
South Africa
UAE
Saudi Arabia
Rest of MEA

FAQs –

How big is the U.S. PRP (Platelet Rich Plasma) and Stem Cell Alopecia Treatment Market?
What is the U.S. PRP (Platelet Rich Plasma) and Stem Cell Alopecia Treatment Market growth?
Which are the regions for investments?
What is the COVID 19 analysis of U.S. PRP (Platelet Rich Plasma) and Stem Cell Alopecia Treatment Market?
Which are the preferred low-cost/best cost sourcing countries?
Which are the key suppliers for the U.S. PRP (Platelet Rich Plasma) and Stem Cell Alopecia Treatment Market?

U.S. PRP (Platelet Rich Plasma) and Stem Cell Alopecia Treatment Market

Source

Recent Posts